Reclassify nicotine replacement therapies as prescription drugs, says Doctor

NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts

Lupin launches patient support program ‘Humrahi‘ for diabetes management

India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045

Menarini strengthens its presence in aesthetic dermatology in India

The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation

Doceree raises US$ 35 million in Series B Funding

Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe

Lupin's Joint Airways Initiative surpasses 10,000 patients

GeoVax secures multi-product license for ProBioGen's AGE1.CR.pIX suspension cell line

The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types

Federal Bank Hormis Memorial Foundation, Tata Trusts and News18 join hands to launch ‘Sanjeevani’

‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic

Lupin acquires five brands from Menarini

Lupin has been exclusively marketing these brands in the Indian market since July 2021

Redcliffe Labs’ diagnostics deliver ~$400 million in economic savings for India

Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health

Takeda reiterates the need of equitable access to healthcare for universal impact

The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services